These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
571 related items for PubMed ID: 26431241
21. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome]. Otto-Buczkowska E, Jarosz-Chobot P, Deja G. Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748 [Abstract] [Full Text] [Related]
22. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome. Wu J, Zhu Y, Jiang Y, Cao Y. Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522 [Abstract] [Full Text] [Related]
25. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. Li L, Chen X, He Z, Zhao X, Huang L, Yang D. J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573 [Abstract] [Full Text] [Related]
30. Clinical Implications of Polycystic Ovary Syndrome in Adolescents. Hachey LM, Kroger-Jarvis M, Pavlik-Maus T, Leach R. Nurs Womens Health; 2020 Apr; 24(2):115-126. PubMed ID: 32273076 [Abstract] [Full Text] [Related]
31. Polycystic Ovary Syndrome among Obese Adolescents. Ybarra M, Franco RR, Cominato L, Sampaio RB, Sucena da Rocha SM, Damiani D. Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509 [Abstract] [Full Text] [Related]
32. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. Morgante G, Cappelli V, Di Sabatino A, Massaro MG, De Leo V. Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824 [Abstract] [Full Text] [Related]
36. Obesity and the polycystic ovary syndrome. Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF. Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153 [Abstract] [Full Text] [Related]
37. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome. Stabile G, Borrielli I, Artenisio AC, Bruno LM, Benvenga S, Giunta L, La Marca A, Volpe A, Pizzo A. J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):177-82. PubMed ID: 24814528 [Abstract] [Full Text] [Related]
39. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Ibáñez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, Dabadghao P, Darendeliler F, Elbarbary NS, Gambineri A, Garcia Rudaz C, Hoeger KM, López-Bermejo A, Ong K, Peña AS, Reinehr T, Santoro N, Tena-Sempere M, Tao R, Yildiz BO, Alkhayyat H, Deeb A, Joel D, Horikawa R, de Zegher F, Lee PA. Horm Res Paediatr; 2017 Jun; 88(6):371-395. PubMed ID: 29156452 [Abstract] [Full Text] [Related]